To view this email as a web page, click here.
 
Enjoy your July Dermatology Times
 
Dermatology Times cover
View the full issue here.
Biologic class differentiators
Dermatology experts offer insight into differentiating factors among TNF-alpha inhibitors, the IL 12/23 antagonist, IL 17 inhibitors and an oral option that carry considerations for managing certain patients.
Learn more.
 
Teledermatology viable for skin cancer diagnosis
Teledermatology may play a role in skin cancer diagnosis, an accumulating body of literature indicates, says one dermatologist.
Learn more.
 
Highlights from Maui Derm 2017
 
Dermatology Times cover
View the full issue here.
Checkpoint inhibitors flourish
Key publications from the past year have enhanced our understanding of immunomodulatory drugs for advanced and metastatic skin cancers. Others could portend significant practice changes in areas such as sentinel lymph node (SLN) biopsy, says one dermatologist.
Learn more.
 
Atopic dermatitis comorbidities
Emerging data suggest that atopic dermatitis is not just a skin disease. In terms of its impact on the whole patient and its potential for multi-organ involvement, it is a systemic disease, according to one dermatologist.
Learn more.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.